An Association Between Glutathione S-Transferase P1 Gene Polymorphism and Younger Age at Onset of Lung Carcinoma
-
2006/10/01
-
Details
-
Personal Author:
-
Description:Background: Among the genes that encode the glutathione S-transferase (GST) superfamily of Phase 2 metabolizing enzymes, GSTP1 has the highest expression in the lung. The polymorphic GSTP1 gene encodes glutathione S-transferase pi, which is an enzyme that detoxifies cigarette carcinogens, such as benzo-[a]-pyrene. The variant GSTP1 GG genotype is associated with lower enzymatic activity and higher DNA adduct levels in human lymphocytes compared with the AA genotype. Methods: The authors evaluated the association of GSTP1 genotypes with lung cancer in 1921 cases and 1343 controls of Caucasian descent by using polymerase chain reaction-restriction fragment length polymorphism techniques. The results were analyzed with multiple logistic regression adjusting for age, gender, smoking status, and pack-years. To investigate specifically the subset of younger lung cancer patients and controls, the effect of age (either as a dichotomous or continuous variable in separate models) was analyzed as a modifying factor of the association between the GSTP1 polymorphism and lung cancer. Results: The GSTP1 GG genotype was not associated with an overall increased risk of lung cancer (adjusted odds ratio, 1.02; 95% confidence interval [95% CI], 0.78-1.34) compared with the GSTP1 AA genotype. In both models that evaluated the gene-age interaction, an overall statistically significant interaction (P < .01) was observed between age and the GG genotype. However, for the model that included age as a dichotomous variable, the odds ratio of lung cancer risk with the GG genotype compared with the AA among individuals age ≤50 years was 2.67 (95% CI, 1.36-5.22); in older individuals, the risk was 0.87 (95% CI, 0.65-1.2). Conclusions: The GSTP1 GG genotype was associated with increased lung cancer susceptibility among younger study participants. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0008-543X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:107
-
Issue:7
-
NIOSHTIC Number:nn:20058611
-
Citation:Cancer 2006 Oct; 107(7):1570-1577
-
Contact Point Address:David C. Christiani, MD, Harvard School of Public Health, 665 Huntington Avenue, Building 1, Room 1402, Boston, MA 02115
-
Email:christi@hsph.harvard.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2007
-
Performing Organization:Harvard School of Public Health
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Cancer
-
End Date:20280630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:5483f6b8099ddada71f957a8a17df7fa970e2cbd7f11ff9536ca1593ce4226963439f1547e95ef9b392ec319919d398559e1100aa3793f303db81e6bfd3e492c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like